Vilastobart (anti-CTLA-4) in MSS mCRC Patients with High Plasma TMB November 10, 2025 1 Forward-Looking Statements and Disclaimers This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including, without limitation, statements regarding plans, timing and expectations related to: development timelines and anticipated milestones for Xilio's programs; the timing and receipt of future payments under Xilio's collaboration or ...